Source:http://linkedlifedata.com/resource/pubmed/id/15561965
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2004-11-24
|
pubmed:abstractText |
The insulin receptor substrate (IRS)-1 is an important component of the insulin signal transduction cascade. Several reports suggest that a Gly-->Arg change in codon 972 is associated with type 2 diabetes and related traits, and a recent meta-analysis reported a modest but nominally significant association with type 2 diabetes (odds ratio [OR] 1.25 in favor of carriers of the Arg allele [95% CI 1.05-1.48). To test the reproducibility of the model in a recent meta-analysis, we examined genotype-phenotype correlation in three large Caucasian samples (not previously reported for this variant) totaling 9,000 individuals (estimated to have >95% power to obtain a P < 0.05 for the OR of 1.25 estimated in the meta-analysis). In our combined sample, comprising 4,279 case and 3,532 control subjects, as well as 1,189 siblings discordant for type 2 diabetes, G972R was not associated with type 2 diabetes (OR 0.96 [0.84-1.10], P = 0.60). Genotype at G972R had no significant effect on various measures of insulin secretion or insulin resistance in a set of Scandinavian samples in whom we had detailed phenotypic data. In contrast, the well-documented associations of peroxisome proliferator-activated receptor gamma P12A and Kir6.2 E23K with type 2 diabetes are both robustly observed in these 9,000 subjects, including an additional (previously unpublished) confirmation of Kir6.2 E23K and type 2 diabetes in the Polish and North American samples (combined OR 1.15 [1.05-1.26], P = 0.001). Despite genotyping 9,000 people and >95% power to reproduce the estimated OR from the recent meta-analysis, we were unable to replicate the association of the IRS-1 G972R polymorphism with type 2 diabetes.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0012-1797
|
pubmed:author |
pubmed-author:AlmgrenPeterP,
pubmed-author:AltshulerDavidD,
pubmed-author:ArdlieKristin GKG,
pubmed-author:BurttNoëlN,
pubmed-author:DalyMark JMJ,
pubmed-author:FlorezJose CJC,
pubmed-author:GaudetDanielD,
pubmed-author:GroopLeifL,
pubmed-author:HirschhornJoel NJN,
pubmed-author:HudsonThomas JTJ,
pubmed-author:LindbladUlfU,
pubmed-author:Orho-MelanderMarjuM,
pubmed-author:SchayerSteveS,
pubmed-author:SjögrenMarketaM,
pubmed-author:SunMariaM,
pubmed-author:TuomiTiinamaijaT
|
pubmed:issnType |
Print
|
pubmed:volume |
53
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3313-8
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15561965-Amino Acid Substitution,
pubmed-meshheading:15561965-Diabetes Mellitus, Type 2,
pubmed-meshheading:15561965-European Continental Ancestry Group,
pubmed-meshheading:15561965-Humans,
pubmed-meshheading:15561965-Insulin Receptor Substrate Proteins,
pubmed-meshheading:15561965-Phenotype,
pubmed-meshheading:15561965-Phosphoproteins,
pubmed-meshheading:15561965-Polymorphism, Single Nucleotide,
pubmed-meshheading:15561965-Scandinavia,
pubmed-meshheading:15561965-Siblings
|
pubmed:year |
2004
|
pubmed:articleTitle |
Association testing in 9,000 people fails to confirm the association of the insulin receptor substrate-1 G972R polymorphism with type 2 diabetes.
|
pubmed:affiliation |
Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|